Josh Mandel-Brehm

Josh current works in Biogen’s in business development group. His efforts are primarily focused on gene therapy with an emphasis on neurology, ophthalmology, and non-malignant Hematology. Previously Josh spent 4 years at Genzyme where he worked in Business Development in the Rare Disease Business Unit. He has an MBA from Michigan and an undergraduate degree in Biology from Washington University in St. Louis.